CLINICAL_TRIALS
withdrawal
· 2014-08-04
Clinical Trial Update: Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test
Summary
The clinical trial assessing Septin9 biomarker for detection of colorectal cancer in FIT-positive patients has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Epigenomics, Inc | Conditions: Colorectal Cancer | Status: WITHDRAWN